Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.05p
   
  • Change Today:
    -0.20p
  • 52 Week High: 14.90p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 1,645,077
  • Market Cap: £15.25m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
5.5% below the market average5.5% below the market average5.5% below the market average5.5% below the market average5.5% below the market average
51.22% above the sector average51.22% above the sector average51.22% above the sector average51.22% above the sector average51.22% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
70.14% above the market average70.14% above the market average70.14% above the market average70.14% above the market average70.14% above the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Price Chg 3m
90.05% below the market average90.05% below the market average90.05% below the market average90.05% below the market average90.05% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
46.44% above the market average46.44% above the market average46.44% above the market average46.44% above the market average46.44% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Momentum 20
14.51% above the market average14.51% above the market average14.51% above the market average14.51% above the market average14.51% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
50.81% below the market average50.81% below the market average50.81% below the market average50.81% below the market average50.81% below the market average
4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
74.96% below the market average74.96% below the market average74.96% below the market average74.96% below the market average74.96% below the market average
29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
22.72% below the market average22.72% below the market average22.72% below the market average22.72% below the market average22.72% below the market average
19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average19.15% above the sector average
Cash
14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average14.35% above the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.05p
Change Today -0.20p
% Change -6.15 %
52 Week High 14.90p
52 Week Low 2.40p
Volume 1,645,077
Shares Issued 500.00m
Market Cap £15.25m
Beta 0.01

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.62% below the market average33.62% below the market average33.62% below the market average33.62% below the market average33.62% below the market average
4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average4.17% above the sector average
Price Trend
88.15% below the market average88.15% below the market average88.15% below the market average88.15% below the market average88.15% below the market average
70.83% below the sector average70.83% below the sector average70.83% below the sector average70.83% below the sector average70.83% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 02-May-2025

Time Volume / Share Price
16:39 275,000 @ 3.00p
16:10 1,820 @ 3.08p
14:11 924 @ 3.25p
11:51 200,000 @ 3.00p
11:33 335 @ 3.05p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page